Dear god PLEASE Posters if you don’t have a relevant university degree in science, experience in this field, or have personal anecdotal experience with the diseases or product DO NOT make submissions to the ODAC.
The professionals speaking at the AdCom will handle the negative submissions. If you really think they won’t know any information that we have access to, you’re deluded. They will know everything we know and more.
If you dont meet any of the above and submit comments, you run the risk of undermining people who deserve to have their story heard, like Meredith from Yankee’s post.
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-299
-
- There are more pages in this discussion • 556 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 29390 | 93.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 14089 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |